Search Results - "MARCUS, Richard J"

Refine Results
  1. 1

    IL-18 and Urinary NGAL Predict Dialysis and Graft Recovery after Kidney Transplantation by HALL, Isaac E, YARLAGADDA, Sri G, COCA, Steven G, ZHU WANG, DOSHI, Mona, DEVARAJAN, Prasad, HAN, Won K, MARCUS, Richard J, PARIKH, Chirag R

    “…Current methods for predicting graft recovery after kidney transplantation are not reliable. We performed a prospective, multicenter, observational cohort…”
    Get full text
    Journal Article
  2. 2

    Effect of High-Dose Erythropoietin on Graft Function after Kidney Transplantation: A Randomized, Double-Blind Clinical Trial by Sureshkumar, Kalathil K, Hussain, Sabiha M, Ko, Tina Y, Thai, Ngoc L, Marcus, Richard J

    “…Delayed graft function (DGF) is associated with adverse long-term outcomes after deceased-donor kidney (DDK) transplantation. Ischemia-reperfusion injury plays…”
    Get full text
    Journal Article
  3. 3

    Association between Peritransplant Kidney Injury Biomarkers and 1-Year Allograft Outcomes by Hall, Isaac E., Doshi, Mona D., Reese, Peter P., Marcus, Richard J., Thiessen-Philbrook, Heather, Parikh, Chirag R.

    “…Current tools to predict outcomes after kidney transplantation are inadequate. The objective of this study was to determine the association of perioperative…”
    Get full text
    Journal Article
  4. 4

    Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy by Hussain, Sabiha M, Marcus, Richard J, Ko, Tina Y, Nashar, Khaled, Thai, Ngoc L, Sureshkumar, Kalathil K

    Published in Experimental and clinical transplantation (01-06-2016)
    “…This study explored the safety of early steroid withdrawal in recipients of expanded criteria deceased-donor kidney transplants. Using the Organ Procurement…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Steroid maintenance in repeat kidney transplantation : influence of induction agents on outcomes by Sureshkumar, Kalathil K., Husayn, Sabihah M., Nashshar, Khalid, Marcus, Richard J.

    “…The influence of steroid maintenance on the outcomes of repeat kidney transplant (RKT) recipients with respect to induction type is unclear. Using the Organ…”
    Get full text
    Journal Article
  7. 7

    Marked variation in the definition and diagnosis of delayed graft function: a systematic review by Yarlagadda, Sri G., Coca, Steven G., Garg, Amit X., Doshi, Mona, Poggio, Emilio, Marcus, Richard J., Parikh, Chirag R.

    Published in Nephrology, dialysis, transplantation (01-09-2008)
    “…Background. The term delayed graft function (DGF) is commonly used to describe the need for dialysis after receiving a kidney transplant. DGF increases…”
    Get full text
    Journal Article
  8. 8

    Gender differences in vascular access in hemodialysis patients in the United States: Developing strategies for improving access outcome by Marcus, Richard J., MD, Marcus, Dawn A., MD, Sureshkumar, Kalathil K., MD, Hussain, Sabiha M., MD, McGill, Rita L., MD

    Published in Gender medicine (01-09-2007)
    “…Abstract Background: Patients undergoing chronic hemodialysis (HD) require placement of permanent vascular access with the creation of an arteriovenous fistula…”
    Get full text
    Journal Article
  9. 9

    Influence of Induction Modality on the Outcome of Deceased Donor Kidney Transplant Recipients Discharged on Steroid-Free Maintenance Immunosuppression by SURESHKUMAR, Kalathil K, THAI, Ngoc L, HUSSAIN, Sabiha M, KO, Tina Y, MARCUS, Richard J

    Published in Transplantation (27-04-2012)
    “…Over last several years, alemtuzumab induction has been increasingly used in kidney transplantation especially in patients maintained on steroid-free…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Inpatient Venous access Practices: PICC Culture and the Kidney Patient by McGill, Rita L., Tsukahara, Tomoki, Bhardwaj, Rahul, Kapetanos, Anastasios T., Marcus, Richard J.

    Published in The journal of vascular access (01-05-2015)
    “…Purpose Depleted venous access is frequently cited as a reason for low fistula achievement. These quality assurance studies were designed to clarify the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Urine cystatin C as a biomarker of proximal tubular function immediately after kidney transplantation by Hall, Isaac E, Koyner, Jay L, Doshi, Mona D, Marcus, Richard J, Parikh, Chirag R

    Published in American journal of nephrology (01-01-2011)
    “…Clinical methods to predict allograft function soon after kidney transplantation are ineffective. We analyzed urine cystatin C (CyC) in a prospective…”
    Get more information
    Journal Article
  14. 14

    Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation by Sureshkumar, Kalathil K, Hussain, Sabiha M, Marcus, Richard J, Ko, Tina Y, Khan, Akhtar S, Tom, Kusum, Vivas, Carlos A, Parris, George, Jasnosz, Katherine M, Thai, Ngoc L

    Published in Clinical nephrology (01-03-2012)
    “…Antibody-mediated rejection (AMR) following renal transplantation is less responsive to conventional anti-rejection therapies. Plasmapheresis (PP), intravenous…”
    Get more information
    Journal Article
  15. 15

    Quality of life after organ transplantation in type 1 diabetics with end-stage renal disease by Sureshkumar, Kalathil K, Patel, Bhavesh M, Markatos, Angelo, Nghiem, Dai D, Marcus, Richard J

    Published in Clinical transplantation (01-01-2006)
    “…:  Quality of life (QOL) should be an important consideration while choosing therapeutic options for patients with type 1 diabetes mellitus (DM) and end‐stage…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Treatment of antibody-mediated rejection in kidney transplant recipients: a single-center experience with a bortezomib-based regimen by Nigos, Janice G, Arora, Swati, Nath, Parineesha, Hussain, Sabiha M, Marcus, Richard J, Ko, Tina Y, Sureshkumar, Kalathil K

    Published in Experimental and clinical transplantation (01-12-2012)
    “…Antibody-mediated rejection after kidney transplant is less responsive to conventional antirejection therapies. The proteasome inhibitor bortezomib has…”
    Get full text
    Journal Article
  18. 18

    Sorbent Hemodialysis: Clinical Experience With New Sorbent Cartridges and Hemodialyzers by McGill, Rita L, Bakos, Jane R, Ko, Tina, Sandroni, Stephen E, Marcus, Richard J

    Published in ASAIO journal (1992) (01-11-2008)
    “…To recycle spent dialysate, a sorbent hemodialyzer uses a purification cartridge, adapted from water reclamation systems originally designed for the aerospace…”
    Get full text
    Journal Article
  19. 19

    Biofilms in nephrology by Marcus, Richard J, Post, J Christopher, Stoodley, Paul, Hall-Stoodley, Luanne, McGill, Rita L, Sureshkumar, Kalathil K, Gahlot, Vikram

    Published in Expert opinion on biological therapy (01-08-2008)
    “…Biofilms are bacterial communities ubiquitous to moist environments. Biofilm formation is a factor in the development and persistence of infectious diseases…”
    Get more information
    Journal Article
  20. 20

    Antibody-mediated rejection following renal transplantation by Sureshkumar, Kalathil K, Hussain, Sabiha M, Carpenter, Barbara J, Sandroni, Stephen E, Marcus, Richard J

    Published in Expert opinion on pharmacotherapy (01-05-2007)
    “…Antibody-mediated rejection (AMR) accounts for 20-30% of all acute rejection episodes following renal transplantation. AMR is generally less responsive to…”
    Get more information
    Journal Article